The Goldman Sachs Group, Inc. 13D and 13G filings for Vincerx Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-09 5:09 pm Sale | 2024-03-28 | 13G | Vincerx Pharma, Inc. VINC | GOLDMAN SACHS GROUP INC GS | 31,575 3.000% | -53,908 (-63.06%) | Filing |
| 2024-02-05 5:35 pm Sale | 2023-12-29 | 13G | Vincerx Pharma, Inc. VINC | GOLDMAN SACHS GROUP INC GS | 85,483 8.000% | -21,910 (-20.40%) | Filing |
| 2023-02-10 1:46 pm Purchase | 2023-01-31 | 13G | Vincerx Pharma, Inc. VINC | GOLDMAN SACHS GROUP INC GS | 107,392 10.100% | 3,549 (+3.42%) | Filing |
| 2023-02-08 09:53 am Purchase | 2022-12-30 | 13G | Vincerx Pharma, Inc. VINC | GOLDMAN SACHS GROUP INC GS | 103,844 9.800% | 103,844 (New Position) | Filing |